Having shown the potential Mcl-1 suppression in H460 cells, we next confirmed the Mcl-1- and Bcl-2-targeting activity of TM-(–)-18 and TM-(–)-4a in primary lung cancer cells. This evidence concerns the gene BCL2 and lung carcinoma.